Download MendeleySelective small-molecule inhibition of an RNA structural element.
Howe, J.A., Wang, H., Fischmann, T.O., Balibar, C.J., Xiao, L., Galgoci, A.M., Malinverni, J.C., Mayhood, T., Villafania, A., Nahvi, A., Murgolo, N., Barbieri, C.M., Mann, P.A., Carr, D., Xia, E., Zuck, P., Riley, D., Painter, R.E., Walker, S.S., Sherborne, B., de Jesus, R., Pan, W., Plotkin, M.A., Wu, J., Rindgen, D., Cummings, J., Garlisi, C.G., Zhang, R., Sheth, P.R., Gill, C.J., Tang, H., Roemer, T.(2015) Nature 526: 672-677
- PubMed: 26416753 Search on PubMed
- DOI: https://doi.org/10.1038/nature15542
- Primary Citation Related Structures:
5C45 - PubMed Abstract:
Riboswitches are non-coding RNA structures located in messenger RNAs that bind endogenous ligands, such as a specific metabolite or ion, to regulate gene expression. As such, riboswitches serve as a novel, yet largely unexploited, class of emerging drug targets. Demonstrating this potential, however, has proven difficult and is restricted to structurally similar antimetabolites and semi-synthetic analogues of their cognate ligand, thus greatly restricting the chemical space and selectivity sought for such inhibitors. Here we report the discovery and characterization of ribocil, a highly selective chemical modulator of bacterial riboflavin riboswitches, which was identified in a phenotypic screen and acts as a structurally distinct synthetic mimic of the natural ligand, flavin mononucleotide, to repress riboswitch-mediated ribB gene expression and inhibit bacterial cell growth. Our findings indicate that non-coding RNA structural elements may be more broadly targeted by synthetic small molecules than previously expected.
- Merck Research Laboratories, Kenilworth, New Jersey 07033, USA.
Organizational Affiliation:
